Developing a treatment for Lassa fever virus
Official title: Task B06: PROCESS DEVELOPMENT AND SYNTHESIS OF A THERAPEUTIC FOR LASSA FEVER VIRUS
Funded at Sri International · NIH-11250785 · Data updated 2026-11-12
This study is working on developing a new treatment for Lassa fever, aiming to find safe and effective options that could help people who are affected by this serious illness.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sri International NIH-funded |
| Lab location | 1 site (Menlo Park, United States) |
| Project start | July 25, 2019 |
| Project end | July 1, 2020 |
| Funding year | 2025 |
| Award (this year) | $1,004 |
| NIH project number | 272201800001I-P00005-759301900135-1 |
| Project ID | NIH-11250785 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals at risk of Lassa fever infection or those who have been diagnosed with the virus.
✕Less likely to help
Patients with other viral infections or those not at risk for Lassa fever may not benefit from this research.
What this research studies
This research focuses on creating a therapeutic agent for Lassa fever virus, a serious infectious disease. The approach involves preclinical development, which includes planning, evaluating potential treatments, and conducting laboratory tests to assess safety and effectiveness. Researchers will identify promising compounds and manufacture them under strict quality standards, followed by testing in both laboratory and animal models to understand how the treatment works and its potential side effects.
Why it matters
Potential benefit: If successful, this research could lead to an effective treatment for Lassa fever, improving outcomes for patients infected with the virus.
How similar studies have gone: While there have been efforts to develop treatments for Lassa fever, this specific approach is part of ongoing research and may offer novel insights into effective therapies.
Where this research is happening
-
Sri International
Menlo Park, United States Active
Researchers
- Principal investigator: Mirsalis, Jon — Sri International
- Study coordinator: Mirsalis, Jon
Related research
Other NIH-funded projects on the same topics.
-
Broad antiviral drugs that target coronaviruses and other viruses
A research program aims to identify small molecules that can block multiple viruses, focusing first on coronaviruses, to help create drugs that can treat future outbreaks.
-
Finding broadly protective antibodies against Crimean-Congo Hemorrhagic Fever
Researchers will study blood from people who survived CCHF to find human antibodies that protect against multiple virus variants, with early tests in animal models to check their breadth.
-
Antivirals for hemorrhagic fever viruses like LASV, SFTSV, and EBOV
A multi-institutional effort to find and validate antiviral compounds that block key viral proteins from LASV, SFTSV, and EBOV to help people at risk from serious hemorrhagic fevers.
-
A New Model for Valley Fever: Studying Coccidioides Infection with Volatile Clues in Wax Moths
Researchers are testing a new, cheaper model using wax moths to study Valley Fever caused by Coccidioides, with the goal of understanding how the infection behaves and how it could be diagnosed or treated.
-
Halogen-modified nucleoside analogs to fight yellow fever virus
Aims to develop new oral medicines that could prevent or treat yellow fever by using specially modified building blocks that stop the virus from growing.
-
Understanding Guanarito virus and building countermeasures for Venezuelan hemorrhagic fever
This project studies how Guanarito virus causes disease and aims to develop vaccines or treatments to protect people in areas where Venezuelan hemorrhagic fever occurs.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.